RE:RE:RE:RE:RE:RE:RE:RE:Newbies...ignore the vapid FUD attempts...Lesalpes, let's just clear htis up once and for all shall we. No-one works for me, I do not short, nor do I work in finance. I'm a retail investor like most here.
NO matter, when ONCY announces in 2023 that they're not going to run the Phase III for mBC, you can thank me for having bailed now.
For all this marvellous data, there is practically zero institutional interest in this company...All I see is pps destruction of over 96% in 25 years, years of delayed trials, inconclusive results from every trial (due to too few patients on trial), and BS from senior management.
I'm not bashing Pelareorep, I'm bashing its management team for failing spectacularly to get this further than it is. WE still DO NOT know conclusively if Pela+Pax+CPI is better than Pela+Pax. And if it isn't, then the last 5 years were a complete waste of time and money... your money, and my money.